Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Travere Therapeutics, Inc.

NASDAQ: TVTX · Life Sciences · 4 alerts · CIK 1438533

Share price
$49.70Close, Nov 16
Market cap
$4.77B
Shares outstanding
95.99MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Travere Therapeutics, Inc. filings on SEC EDGAR ↗

4:11 PM ET 8-K
Leadership Change

Travere Therapeutics Leadership Change

Travere Therapeutics announced that Eric Dube, Ph.D., will step down as President, CEO, and Board member effective December 1, 2026. Bradley L. Campbell, former CEO of Amicus Therapeutics, has been appointed as his successor. Dr. Dube will remain as an Executive Advisor through February 15, 2027, to facilitate a smooth leadership transition.

Counterparty
Bradley L. Campbell

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.